Cancers, Vol. 16, Pages 1557: Glioma Stem Cells & mdash;Features for New Therapy Design

Cancers, Vol. 16, Pages 1557: Glioma Stem Cells—Features for New Therapy Design Cancers doi: 10.3390/cancers16081557 Authors: Nives Pećina-Šlaus Reno Hrašćan On a molecular level, glioma is very diverse and presents a whole spectrum of specific genetic and epigenetic alterations. The tumors are unfortunately resistant to available therapies and the survival rate is low. The explanation of significant intra- and inter-tumor heterogeneity and the infiltrative capability of gliomas, as well as its resistance to therapy, recurrence and aggressive behavior, lies in a small subset of tumor-initiating cells that behave like stem cells and are known as glioma cancer stem cells (GCSCs). They are responsible for tumor plasticity and are influenced by genetic drivers. Additionally, GCSCs also display greater migratory abilities. A great effort is under way in order to find ways to eliminate or neutralize GCSCs. Many different treatment strategies are currently being explored, including modulation of the tumor microenvironment, posttranscriptional regulation, epigenetic modulation and immunotherapy.
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research